MENU
BDTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Black Diamond Therapeutics (BDTX) Earnings Date & Reports

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer... Show more

A.I. Advisor
published Earnings

BDTX is expected to report earnings to fall 125.44% to -24 cents per share on August 12

Black Diamond Therapeutics BDTX Stock Earnings Reports
Q2'25
Est.
$-0.25
Q1'25
Beat
by $0.93
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.03
The last earnings report on May 13 showed earnings per share of 98 cents, beating the estimate of 5 cents. With 1.30M shares outstanding, the current market capitalization sits at 141.02M.
View a ticker or compare two or three
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 252-0848
Employees
54
Web
https://www.blackdiamondtherapeutics.com